Literature DB >> 3185521

Topography and functions of sulfhydryl groups of the human erythrocyte glucose transport mechanism.

R E Abbott1, D Schachter.   

Abstract

Membrane-impermeant and -permeant maleimides were applied to characterize the location and function of the sulfhydryl (SH) groups essential for the facilitated diffusion mediated by the human erythrocyte glucose transport protein. Three such classes have been identified. Type I SH is accessible to membrane-impermeant reagents at the outer (exofacial) surface of the intact erythrocyte. Alkylation of this class inhibits glucose transport; D-glucose and cytochalasin B protect against the alkylation. Type II SH is located at the inner (endofacial) surface of the membrane and is accessible to the membrane-impermeant reagent glutathione maleimide only after lysis of the erythrocyte. D-glucose enhances, while cytochalasin B reduces, the alkylation of Type II SH by maleimides. Reaction of Types I and II SH with an impermeant maleimide increases the half-saturation concentration for binding of D-glucose to erythrocyte membranes. By contrast, inactivation of Type III SH markedly decreases the half-saturation concentration for the binding of D-glucose and other transported sugars. Type III SH is inactivated by the relatively lipid-soluble reagents N-ethylmaleimide (NEM) and dipyridyl disulfide, but not by the impermeant glutathione maleimide. Type III SH is thus located in a hydrophobic membrane domain. A kinetic model constructed to explain these observations indicates that Type III SH is required for the translocation event in a hydrophobic membrane domain which leads to the dissociation of glucose bound to transport sites at the membrane surfaces.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3185521     DOI: 10.1007/bf00242521

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  12 in total

1.  INHIBITION OF THE GLUCOSE PERMEABILITY OF HUMAN ERYTHROCYTES BY N-ETHYL MALEIMIDE.

Authors:  A C DAWSON; W F WIDDAS
Journal:  J Physiol       Date:  1963-10       Impact factor: 5.182

2.  STUDIES OF THE GLUCOSE-TRANSPORT SYSTEM IN THE RABBIT ERYTHROCYTE.

Authors:  D M REGEN; H E MORGAN
Journal:  Biochim Biophys Acta       Date:  1964-01-27

3.  Sugar transport in the red blood cell: structure-activity relationships in substrates and antagonists.

Authors:  P G LEFEVRE
Journal:  Pharmacol Rev       Date:  1961-03       Impact factor: 25.468

4.  The monosaccharide transport system of the human erythrocyte. Solubilization and characterization on the basis of cytochalasin B binding.

Authors:  M A Zoccoli; S A Baldwin; G E Lienhard
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

5.  Sequence and structure of a human glucose transporter.

Authors:  M Mueckler; C Caruso; S A Baldwin; M Panico; I Blench; H R Morris; W J Allard; G E Lienhard; H F Lodish
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

6.  Transport of monosaccharides. I. Asymmetry in the human erythrocyte mechanism.

Authors:  E R Batt; D Schachter
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Impermeant maleimides. Oriented probes of erythrocyte membrane proteins.

Authors:  R E Abbott; D Schachter
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

8.  Impermeant maleimides. Identification of an exofacial component of the human erythrocyte hexose transport mechanism.

Authors:  E R Batt; R E Abbott; D Schachter
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

9.  Purification of the cytochalasin B binding component of the human erythrocyte monosaccharide transport system.

Authors:  S A Baldwin; J M Baldwin; F R Gorga; G E Lienhard
Journal:  Biochim Biophys Acta       Date:  1979-03-23

10.  LOCALIZATION OF ERYTHROCYTE MEMBRANE SULFHYDRYL GROUPS ESSENTIAL FOR GLUCOSE TRANSPORT.

Authors:  J VANSTEVENINCK; R I WEED; A ROTHSTEIN
Journal:  J Gen Physiol       Date:  1965-03       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.